183 related articles for article (PubMed ID: 15994954)
21. Reduction of GRP78 expression with siRNA activates unfolded protein response leading to apoptosis in HeLa cells.
Suzuki T; Lu J; Zahed M; Kita K; Suzuki N
Arch Biochem Biophys; 2007 Dec; 468(1):1-14. PubMed ID: 17936241
[TBL] [Abstract][Full Text] [Related]
22. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.
Pyrko P; Schönthal AH; Hofman FM; Chen TC; Lee AS
Cancer Res; 2007 Oct; 67(20):9809-16. PubMed ID: 17942911
[TBL] [Abstract][Full Text] [Related]
23. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
24. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands.
Arap MA; Lahdenranta J; Mintz PJ; Hajitou A; Sarkis AS; Arap W; Pasqualini R
Cancer Cell; 2004 Sep; 6(3):275-84. PubMed ID: 15380518
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of endoplasmic reticulum molecular chaperone GRP94 and GRP78 in human lung cancer tissues and its significance.
Wang Q; He Z; Zhang J; Wang Y; Wang T; Tong S; Wang L; Wang S; Chen Y
Cancer Detect Prev; 2005; 29(6):544-51. PubMed ID: 16297569
[TBL] [Abstract][Full Text] [Related]
26. Effect of inhibitors of poly(ADP-ribose) polymerase on the induction of GRP78 and subsequent development of resistance to etoposide.
Chatterjee S; Cheng MF; Berger RB; Berger SJ; Berger NA
Cancer Res; 1995 Feb; 55(4):868-73. PubMed ID: 7850801
[TBL] [Abstract][Full Text] [Related]
27. Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
Hu-Lowe DD; Zou HY; Grazzini ML; Hallin ME; Wickman GR; Amundson K; Chen JH; Rewolinski DA; Yamazaki S; Wu EY; McTigue MA; Murray BW; Kania RS; O'Connor P; Shalinsky DR; Bender SL
Clin Cancer Res; 2008 Nov; 14(22):7272-83. PubMed ID: 19010843
[TBL] [Abstract][Full Text] [Related]
28. Expression of stress response protein Grp78 is associated with the development of castration-resistant prostate cancer.
Pootrakul L; Datar RH; Shi SR; Cai J; Hawes D; Groshen SG; Lee AS; Cote RJ
Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5987-93. PubMed ID: 17062670
[TBL] [Abstract][Full Text] [Related]
29. Glucose-deprived HT-29 human colon carcinoma cells are sensitive to verrucosidin as a GRP78 down-regulator.
Park HR; Ryoo IJ; Choo SJ; Hwang JH; Kim JY; Cha MR; Shin-Ya K; Yoo ID
Toxicology; 2007 Jan; 229(3):253-61. PubMed ID: 17161515
[TBL] [Abstract][Full Text] [Related]
30. Suppression of stress protein GRP78 induction in tumor B/C10ME eliminates resistance to cell mediated cytotoxicity.
Sugawara S; Takeda K; Lee A; Dennert G
Cancer Res; 1993 Dec; 53(24):6001-5. PubMed ID: 8261413
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress.
Pyrko P; Kardosh A; Wang W; Xiong W; Schönthal AH; Chen TC
Cancer Res; 2007 Nov; 67(22):10920-8. PubMed ID: 18006837
[TBL] [Abstract][Full Text] [Related]
32. cis-3, 4', 5-Trimethoxy-3'-aminostilbene disrupts tumor vascular perfusion without damaging normal organ perfusion.
Durrant D; Corwin F; Simoni D; Zhao M; Rudek MA; Salloum FN; Kukreja RC; Fatouros PP; Lee RM
Cancer Chemother Pharmacol; 2009 Jan; 63(2):191-200. PubMed ID: 18365199
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of molecular chaperone 78-kd glucose-regulated protein/immunoglobulin-binding protein expression involved in enhancement of human RS cell mutability.
Hirano J; Kita K; Sugaya S; Ichimura Y; Yamamori H; Nakajima N; Suzuki N
Pancreas; 2008 Jan; 36(1):e7-14. PubMed ID: 18192872
[TBL] [Abstract][Full Text] [Related]
34. Retrovirus-mediated transduction of a short hairpin RNA gene for GRP78 fails to downregulate GRP78 expression but leads to cisplatin sensitization in HeLa cells.
Suzuki T; Lu J; Hu G; Kita K; Suzuki N
Oncol Rep; 2011 Mar; 25(3):879-85. PubMed ID: 21225231
[TBL] [Abstract][Full Text] [Related]
35. GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer.
Lee E; Nichols P; Spicer D; Groshen S; Yu MC; Lee AS
Cancer Res; 2006 Aug; 66(16):7849-53. PubMed ID: 16912156
[TBL] [Abstract][Full Text] [Related]
36. Mammalian tumor xenografts induce neovascularization in zebrafish embryos.
Nicoli S; Ribatti D; Cotelli F; Presta M
Cancer Res; 2007 Apr; 67(7):2927-31. PubMed ID: 17409396
[TBL] [Abstract][Full Text] [Related]
37. Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus.
Del Bufalo D; Ciuffreda L; Trisciuoglio D; Desideri M; Cognetti F; Zupi G; Milella M
Cancer Res; 2006 Jun; 66(11):5549-54. PubMed ID: 16740688
[TBL] [Abstract][Full Text] [Related]
38. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer.
Yuan P; Wang L; Wei D; Zhang J; Jia Z; Li Q; Le X; Wang H; Yao J; Xie K
Cancer; 2007 Dec; 110(12):2682-90. PubMed ID: 17973266
[TBL] [Abstract][Full Text] [Related]
40. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.
Rocchi P; Beraldi E; Ettinger S; Fazli L; Vessella RL; Nelson C; Gleave M
Cancer Res; 2005 Dec; 65(23):11083-93. PubMed ID: 16322258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
